Search Tag: Immunicom

Executive Health Management

Immunicom Appoints Dr. Annette Marleau as Chief Technology Officer

2022 17 Feb

Dr. Marleau will direct the Company’s R&D efforts and advance its pipeline of subtractive therapies treating cancer and other terminal diseases Immunicom, Inc., a clinical-stage biotechnology company pioneering subtractive therapies to treat unmet medical needs in cancer and other terminal diseases, announced that Dr. Annette Marleau is assuming... Read more